Companies jointly developing and commercializing eplontersen in the U.S. AstraZeneca adds Latin America as part of its exclusive rights for rest of world CARLSBAD, Calif. , July 28, 2023 /PRNewswire/ — Ionis Pharmaceuticals , Inc. (Nasdaq: IONS) today announced it has expanded its existing
Read more